Cancer Weekly articles from November 2002

Cancer Weekly archives from November 2002

DNAzymes act as cancer fighting agents.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Man-made agents described as DNAzymes could some day be major players in the fight against cancer. Researchers in Baltimore, Maryland recently explained in...

Das-1 immunostain distinguishes some classes of liver tumors from others.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Das-1 immunostain can distinguish between different types of liver tumors, according to a study conducted at a Pennsylvania University. In one of the few...

OSU studies risk related to beef consumption.(Ohio State University, breast cancer)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Scientists concerned that a growth promoter widely used in the U.S. cattle industry may increase the risk of breast cancer are launching the first-ever study comparing beef consumption with elevated...

Cytokine may play role in gastric carcinoma angiogenesis.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new study has revealed a link between interleukin-6 and gastric cancer angiogenesis. Though interleukin (IL)-6 and the angiogenesis modulator vascular...

P53 suppressor gene studied.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Montefiore Medical Center researchers are studying a new drug that has the potential to fight recurrent and highly resistant head and neck cancer. Montefiore is the only medical center in New York City...

IMRT promising for treatment with minimal side effects.(intensity-modulated radiation therapy)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Intensity-modulated radiation therapy (IMRT) promises to be superior to conventional radiation therapies for the treatment of Hodgkin disease, according to a new study presented at the American Society...

Genetic findings in monkey herpes virus could aid research in human cancer.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- For the first time, scientists at the University of North Carolina (UNC) at Chapel Hill have discovered similar gene activity profiles between a herpes virus that affects rhesus macaque monkeys and a...

Conventional CT models not adequate for modeling lung tumors during breathing.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Conventional CT scans do not adequately take into account the way lung tumors move as patients breathe, according to a new study presented October 8, 2002, at the American Society for Therapeutic...

Cancer treatment developer names CFO, strengthens board of directors.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- ARC Pharmaceuticals, Inc., announced the appointment of Bruce Hay to the position of CFO. Hay, William Adams, and Dr. Jerry Gray have also been appointed to the board of directors. "We are pleased...

Judy H. Chiao, MD, named VP, oncology clinical R&D of drug discovery company.(Aton Pharma, Inc.)(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Aton Pharma, Inc., a privately held biopharmaceutical company with the mission to discover and develop therapeutics for cancer and other diseases, announced that Judy H. Chiao, MD, has been promoted to...

DTI-015 developer completes enrollment of phase I/II trial of the new drug.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Direct Therapeutics, Inc., a privately held drug development company, announced that it has concluded patient enrollment and treatment for its multicenter phase I/II study of DTI-015, a new...

Avon Foundation awards $2.785M grant for research and education.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- To encourage and promote breast cancer research and education, particularly among young investigators in underserved countries, the American Association for Cancer Research (AACR) has been awarded a...

Brachytherapy is an effective treatment.(for breast cancer)(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Brachytherapy is an effective modality of treatment for breast cancer, according to a new study presented at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in New Orleans....

FDA approves inclusion of gene test in Herceptin labeling.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) anticipates that more breast cancer patients will benefit from use of its Vysis PathVysion fluorescence in situ hybridization (FISH) test as a result of the U.S. Food and Drug...

Lumpectomy just as effective as mastectomy.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- New results from a long-term study of breast cancer patients reveal that patients who underwent lumpectomies fared just as well as patients who had mastectomies, according to a new study presented in...

Medical advice to women contradictory, confusing.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Call it the year of mixed messages: first came debate about mammography's value, then the news that long-term use of the hormones estrogen and progestin raise the risk of breast cancer and heart attacks...

Plant-based estrogens and genetic variations in their breakdown to be studied.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- The role of plant-based estrogens in modifying breast cancer risk is the subject of a 5-year research study and intervention to be conducted by nutritional epidemiologists at the University at Buffalo...

Postmastectomy radiation reduces the risk of recurrence.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Radiation after mastectomy reduces recurrence rates for breast cancer patients, according to a new study at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in New Orleans....

Alfacell, NCI expand research collaboration.(National Cancer Institute)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Alfacell Corp. (ACEL) has expanded its research collaboration with the National Cancer Institute (NCI), one of the institutes of the National Institutes of Health (NIH) in Rockville, Maryland. ...

Company to challenge FDA delay of manufactured tamoxifen launch.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) has announced that it disagrees with a letter, received from the U.S. Food and Drug Administration (FDA), which retroactively alters the approval date of Barr's...

Investigational new drug applications filed for M-Vax, O-Vax.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) announced the submission of investigational new drug applications (IND) for M-Vax and O-Vax, its AC Vaccine technology product candidates for the treatment of melanoma...

One day, nanotechnology could be used to track and kill cancer cells.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- A new, patented nanotechnology that one day may allow cancer patients to receive treatments through an MRI procedure in a doctor's office is being developed by scientists at the University at Buffalo's...

Team challenges nature of phase I trials for evaluating antiangiogenic therapy.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The members of a multinational research team have challenged the conventional strategies of phase I trials for evaluating antiangiogenic therapies targeting...

Zentaris inks agreement with oncology-focused company for oral signal transduction modulator.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Access Oncology, Inc., of New York City announced at the Bear Stearns Healthcare Conference that it has entered into a definitive license agreement with Zentaris AG of Frankfurt, Germany to develop...

Automated imaging company releases new clinical system.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. (AICX) announced the release of Ariol, the company's latest cellular imaging system. Ariol is a high-throughput system designed to automate and standardize the analysis of...

Combining chemotherapy, radiation therapy improves survival odds.(cervical cancer)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- The updated results of a study confirm preliminary findings that chemotherapy can increase the chances of survival for some cervical cancer patients, according to a new study presented at the October...

New treatment for sexual dysfunction.(in cervical cancer patients)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Cervical cancer patients who were treated with radiation therapy now have a new tool for fighting sexual side effects, according to a new study presented in October 2002 at the American Society for...

Women with advanced disease need varied therapy, study shows.(cervical cancer)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Researchers at Washington University School of Medicine in St. Louis have found that women with advanced cervical cancer have different odds of survival depending on how far the cancer has spread, as...

Data reported from preclinical DACH platinum study in mice.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc. (AKC) reported data at the 2nd International Symposium on Tumor Targeted Delivery Systems indicating its experimental compound, AP5346, in the B16 murine melanoma model,...

Vitamin-mediated tumor targeting data confirm enhanced drug uptake.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc. (AKC) presented at the 2nd International Symposium on Tumor Targeted Delivery Systems in vitro and in vivo data on vitamin targeted polymers. Linking drugs to polymers...

CRO announces services agreement with MedImmune.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- BioReliance Corp. (BREL) announced that it has entered into a laboratory services agreement with MedImmune, Inc. Under the agreement, BioReliance will perform a range of assays for certain of...

Controlled tissue resection system minimizes collateral tissue damage.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- ACMI announced it has received an excellent response from surgeons using its Vista CTR (Controlled Tissue Resection) system for performing bipolar resection of the prostate and bladder tumors...

Company licenses TransMID product to Nycomed.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- KS Biomedix Holdings, plc, (KSB) has appointed Nycomed as the European licensee for its TransMID product in a licensing agreement worth up to $60 million. TransMID is a biopharmaceutical product in...

High-risk tumors largely resist chemotherapy attack.(head and neck cancer)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Adding chemotherapy to radiation therapy and surgery failed to significantly improve control of high-risk, resected head and neck cancers, according to a new study presented at the October 2002 American...

European trial finds old lung cancer treatment may still be best.(cisplatin)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- The first clinical trial to compare directly two of the most widely used drugs in advanced lung cancer, cisplatinin and carboplatin (both in combination with paclitaxel) - have concluded that the older...

Combination of gene-loaded vectors suppresses human skin cancer.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A combination of gene therapies has produced highly beneficial results in murine models of human melanoma. Scientists report melanoma has become one of the...

Study finds declines in 20- to 44-year-olds.(in melanoma death rates)(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- U.S. melanoma deaths dropped significantly in people ages 20 to 44 years over the past 3 decades, thanks in part to educational campaigns about the dangers of too much sun, researchers say. The...

Cancer survival rates higher than previously assumed.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Conventional estimates for life expectancy after cancer diagnosis have been too pessimistic, suggests a study in the Lancet. There are two main ways of quantifying survival estimates after cancer...

FDA awards EntreMed orphan drug grant for Endostatin trial.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc. (NASDAQ:ENMD), which focuses on angiogenesis research and product development, announced it received notification that it has been awarded a clinical research grant from the U.S. Food and...

Combining ionizing radiation and radioimmunotherapy appears safe.(for non-Hodgkin lymphoma)(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Combining external beam radiotherapy and the immunotherapy drug Zevalin appears to be a safe and effective treatment for patients with some of the most common types of non-Hodgkin lymphoma, according to...

Company updates RSR13 phase II study results.(for non-small cell lung cancer)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced updated positive survival results from a phase II clinical trial evaluating the use of RSR13 (efaproxiral) in patients with locally advanced, unresectable,...

Patient recruitment target reached in pivotal trial of pemtumomab.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Antisoma plc, a biopharmaceutical company based in Britain, announced it has reached the target for patient recruitment in its pivotal phase III study of pemtumomab in ovarian cancer. Four hundred...

Phase III clinical results for 4-month product reported.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc. (NASDAQ:ATRX) announced the presentation of phase III clinical results for the company's Eligard 30 mg (leuprolide acetate for injectible suspension) prostate cancer treatment...

Spice may protect skin during treatment for cancer.(curry)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Cancer researchers at the University of Rochester Medical Center have found that curcumin, a substance in curry long believed to have health benefits, seems to protect skin during radiation therapy....

Looking at sphincter preservation and quality of life.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Roxanna Guilford, senior medical writer - A study of 130 rectal cancer patients treated with neoadjuvant chemoradiation reveals that there is no quality of life difference between those who received...

Company restructures AxCell subsidiary to support oncology focus.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Cytogen Corp. (CYTO), a biopharmaceutical company with an established and growing product line in oncology, announced a realignment of its AxCell Biosciences subsidiary in an effort to reduce expenses...

Researchers find promising preliminary results from gene therapy.(thyroid cancer)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Roxanna Guilford, senior medical writer - Research by University of Pennsylvania -Philadelphia offers potential promise for thyroid cancer patients, especially those with tumors resistant to iodine...

Natural insecticide identified as potential cancer prevention agent.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- The use of deguelin, a natural plant extract most commonly used as an insecticide in Africa and South American, inhibits the growth of precancerous and cancerous lung cells, with no toxic effects on...

Antibody halts tumor growth in prostate cancer model.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Tumors in animal models of androgen-independent human prostate cancer stop growing almost completely when treated with paclitaxel and antibody to vascular...

Gene-attenuated viruses demonstrate anticancer effect.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Different combinations of E1B gene deletions can make genetically altered adenoviruses attractive candidates for cancer gene therapy. "For the aim of...

Pain control possible with gene therapy.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- By "programming" a herpes simplex virus to deliver a gene-mediated pain-blocking protein at the cellular level, University of Pittsburgh researchers have been able to significantly reduce...

Type 2 diabetes increases breast cancer risk.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The large Atherosclerosis Risk in Communities (ARIC) study yielded data that indicate women with type 2 diabetes have a slightly higher risk of...

Vaccine effective against melanoma in mice.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Immunization with a vaccine containing mouse fibroblasts transfected with DNA from B16 mouse melanoma cells that expressed syngeneic and allogeneic...

Desperation drives patients to alternative remedies.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Oncologists have been urged to be more responsive to cancer patients who want to try alternative medicines. Speaking October 18, 2002, at the European Society for Medical Oncology Congress in...

Phase II preclinical tests to commence for nanoparticle-based technology.(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Advectus Life Sciences, Inc., has been advised by the University of North Carolina Brain Tumor Center at Chapel Hill as to the schedule details of the second phase of the preclinical study of its...

20% of mammogram-detected cancers are in situ lesions of unknown aggressiveness.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Of cancers detected by screening mammography, approximately 20% are ductal carcinoma in situ (DCIS), a noninvasive tumor contained within the walls of the breast duct, according to a multistate study...

COX-2 inhibitors may delay onset.(of breast cancer)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- The use of a selective COX (cyclooxygenase)-2 inhibitor (celecoxib) significantly reduced the incidence of breast cancer in HER-2/neu overexpressing mice, according to a study presented October 15,...

Doctors surprised that older women patients can tolerate powerful treatment.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Oncologists may be anxious about treating older women with breast cancer in the same way that they would treat younger patients, but research conducted at the Institute Paoli Calmettes in Marseilles,...

FDA marketing authorization received for imaging technology.(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Instrumentarium Imaging, a division of Instrumentarium , announced that the U.S. Food and Drug Administration has cleared the Delta 32 and Delta 32 TACT diagnostic digital breast imaging systems for...

Maternal alcohol use during pregnancy may increase offspring's risk.(of breast cancer)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Women who drink moderate-to-high quantities of alcohol during pregnancy could be contributing to an increased risk of breast cancer among their daughters, according to a study presented at the first...

Short-term estrogen may offer protection.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Short-term use of pregnancy-level estrogen, designed to mimic pregnancy, is highly effective in protecting women from breast cancer, according to a study presented at the American Association for...

Study finds no link to deodorant use.(breast cancer)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- A new study, prompted by an urban myth spread on the Internet, shows there is no evidence that antiperspirants or deodorants can cause breast cancer. The study, appearing in the Journal of the...

Key patent obtained for p53 targeted chemotherapy.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Introgen Therapeutics, Inc., (INGN) and the University of Texas M.D. Anderson Cancer Center announced that the U.S. Patent and Trademark Office has issued to the Board of Regents of the University of...

Agreement reached for development, commercialization of indolocarbazole.(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Banyu Pharmaceutical Co. Ltd., and Pharmacia Corporation (PHA) announced that they have signed an agreement for the development and commercialization of Banyu's proprietary anticancer compound J-107088...

Alpha particle immunotherapy collaboration formed.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Actinium Pharmaceuticals, Inc., (API) announced its collaboration with Memorial Sloan-Kettering Cancer Center (MSKCC) in the field of alpha particle immunotherapy (APIT) by signing a license,...

NDA submitted for antiemetic.(new drug application)(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Helsinn Healthcare SA, and its partner MGI PHARMA, Inc., announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for palonosetron, their agent for the...

Dendritic cells expressing tumor antigen, GM-CSF elicit potent tumor-specific immune response.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Cotransduction of granulocyte macrophage colony-stimulating factor (GM-CSF) into dendritic cells (DCs) already capable of expressing specific tumor...

Vaccine maker initiates cost reduction program.(Biomira, Inc)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (TSX:BRA) announced that the company has initiated a cost reduction program focused primarily on curtailing earlier research programs in favor of continuing development of its two...

Licensing agreement signed for novel cancer treatment.(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Cyclis Pharmaceuticals, Inc., a privately held biopharmaceutical company developing novel cancer therapeutics, announced that the company has licensed exclusive worldwide rights to broad technology...

NCI/CALGB trial of Genasense plus Gleevec begins.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Genta, Inc., (GNTA), in collaboration with Aventis (AVE), announced the initiation of a new clinical trial that uses its lead anticancer drug, Genasense, in combination with Gleevec (imatinib mesylate;...

Enrollment completed for phase II pilot study of vaccine for metastatic disease.(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (TSX: BRA) announced that the company has completed enrolment of its phase II pilot study of Theratope vaccine for metastatic colorectal cancer. The 20-patient study was...

Oncologists evaluate Chinese herbal medicine.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- An innovative approach to test Chinese herbal medicine using Western research methods has been devised by oncologists in Hong Kong to evaluate the role of herbal medicine in a conventional treatment...

New FDA-cleared calcitonin test launched in U.S., Europe.(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Biomerica, Inc., (BMRA), a global medical technology company, announced it is launching a new U.S. Food and Drug Administration-cleared diagnostic blood test to be sold both in the U.S. and in Europe...

Operating expenses increase 25% in line with new product development for anticancer drug company.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Antisoma plc (ASOM), the biopharmaceutical company developing new drugs for cancer, announced its preliminary results for the year ended June 30, 2002. Commenting on the results, Glyn Edwards, CEO...

Japanese patent covering SAGE technology granted.(Serial Analysis of Gene Expression)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology (GZMO) announced that the Japanese Patent Office has issued Patent No. 3334806 covering its powerful SAGE technology. The patent covers the methodology by which SAGE...

Dendritic cells augment effects of IL-18 gene therapy in fibrosarcoma.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Dendritic cells increase the oncolytic properties of interleukin (IL)-18 gene therapy, researchers say. Preliminary experiments conducted by medical...

Clinical services must catch up.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Despite the immense potential impact of the Human Genome Project on clinical care, there are almost no clinical services available to cope with the demand, warned a London geneticist at a European...

Woodchuck hepatitis virus replication diminishes in preneoplastic lesions.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Preneoplastic lesions in animals infected with a virus similar to hepatitis B virus (HBV) don't contain very many replicating virions, scientists have learned....

Patent advances intellectual property of diagnostic imaging, therapeutic products company.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced the issuance of a new U.S. Patent No. 6,399,068, which covers therapeutic bispecific antibodies for the treatment of cancers, especially B-cell malignancies, such...

Phase III clinical trial of Xyotax for second-line treatment initiated.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Cell Therapeutics, Inc., (CTI) (CTIC), has initiated its Xyotax phase III non-small cell lung cancer trial at 20 centers in the U.S. and anticipates having more than 100 centers initiated by the end of...

ADA awarded $1.2 million continuing education grant.(American Dental Association)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- The American Dental Association (ADA) announced it received a grant of $1.2 million from the U.S. National Cancer Institute to develop and implement a continuing education program for oral health care...

Better survival seen with paclitaxel+cisplatin than with cyclophosphamide-cisplatin.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Women with advanced ovarian cancer (AOC) have a 34% chance of long-term survival when treated with a combination of Taxol (paclitaxel) and cisplatin (TP) compared with those treated with a combination...

License and codevelopment agreement signed for late-stage drug.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- GPC Biotech AG (Frankfurt: GPC) announced that it has signed an agreement with NeoTherapeutics, Inc., (NEOTD) granting GPC Biotech an exclusive worldwide license to satraplatin, an orally administered,...

Study provides direct evidence of the role of telomeres in disease development.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Telomere shortening has been proposed as an early and prevalent marker of prostate cancer process, according to a study presented at the American Association for Cancer Research's first annual...